Joaquin Wong
Neurology with Special Qualifications in Child Neurology · New Orleans, LANPI 1346262128
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (53.2%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Sarepta Therapeutics, Inc. accounts for 70.9% of it on its own, with 35 other manufacturers making up the rest.
Across 310 payments — averaging $90.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sarepta Therapeutics, Inc.$20K
- UCB, Inc.$2K
- Jazz Pharmaceuticals Inc.$828
- Neurelis, Inc.$784
- Eisai Inc.$765
- Argenx US, Inc.$752
- plus $4K from 30 others
What the payments were for
- Consulting fees$14,93053%
- Travel & lodging$3,18111%
- Food & beverage$9,85435%
- Education$840%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sarepta Therapeutics, Inc. | 57 | $19,877 |
| UCB, Inc. | 39 | $1,502 |
| Jazz Pharmaceuticals Inc. | 31 | $828 |
| Neurelis, Inc. | 16 | $784 |
| Eisai Inc. | 24 | $765 |
| Argenx US, Inc. | 7 | $752 |
| PTC Therapeutics, Inc. | 18 | $384 |
| Biogen | 14 | $358 |
| SK Life Science, Inc. | 9 | $221 |
| Johnson & Johnson(2 entities) | 5 | $211 |
| Novartis | 9 | $201 |
| Grifols USA, LLC | 2 | $192 |
| AstraZeneca | 4 | $172 |
| Sunovion Pharmaceuticals Inc. | 10 | $137 |
| Greenwich Biosciences, Inc. | 7 | $135 |
| AbbVie(2 entities) | 2 | $127 |
| Biocodex, Inc. | 3 | $110 |
| Genentech, Inc. | 2 | $108 |
| NS Pharma, Inc. | 6 | $107 |
| Genentech USA, Inc. | 5 | $106 |
| Immedica Pharma US, Inc. | 4 | $100 |
| Biomarin Pharmaceutical Inc. | 6 | $98 |
| Catalyst Pharmaceuticals, Inc. | 3 | $97 |
| Ipsen Biopharmaceuticals, Inc | 4 | $96 |
| Sanofi | 4 | $95 |
| ITF Therapeutics LLC | 3 | $90 |
| Travere Therapeutics, Inc. | 1 | $75 |
| Azurity Pharmaceuticals, Inc. | 3 | $58 |
| Acadia Pharmaceuticals Inc | 2 | $47 |
| Zogenix Inc. | 2 | $46 |
| Novartis Gene Therapies, Inc. (fka Avexis, Inc.) | 1 | $45 |
| Upsher-smith Laboratories LLC | 2 | $37 |
| Aucta Pharmaceuticals, Inc. | 1 | $27 |
| Amneal Pharmaceuticals LLC | 2 | $27 |
| Mirum Pharmaceuticals, Inc. | 1 | $19 |
| Metacel Pharmaceuticals LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$28,049 in reported general payments places this provider in the 85th percentile of 30 neurology with special qualifications in child neurology providers in Louisiana.
See all neurology with special qualifications in child neurology providers in Louisiana →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rufinamide | 15 | $7,226 |
Paid to pharmacies, not to this prescriber.
Other neurology with special qualifications in child neurology in New Orleans
- Ann Henderson TiltonNew Orleans$119K
- Allison ConraveyNew Orleans$15K
- David HoughtonNew Orleans$9K
- Jeremy TolerNew Orleans$9K
- Jessica GautreauxNew Orleans$9K
- Daniella MillerNew Orleans$8K
- Maria WeimerNew Orleans$6K
- Rashmi RaoNew Orleans$5K
- Kelly AngelleNew Orleans$3K
- Kayla PenceNew Orleans$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.